These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1880661)

  • 1. Effects of surfactant therapy on outcome of infants with birth weights of 600 to 750 grams.
    Ferrara TB; Hoekstra RE; Couser RJ; Jackson JC; Anderson CL; Myers TF; Raye JR
    J Pediatr; 1991 Sep; 119(3):455-7. PubMed ID: 1880661
    [No Abstract]   [Full Text] [Related]  

  • 2. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
    Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
    J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
    Stevenson D; Walther F; Long W; Sell M; Pauly T; Gong A; Easa D; Pramanik A; LeBlanc M; Anday E
    J Pediatr; 1992 Feb; 120(2 Pt 2):S3-12. PubMed ID: 1735849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
    Sell M; Cotton R; Hirata T; Guthrie R; LeBlanc M; Mammel M; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S20-5. PubMed ID: 7745507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants.
    Lang MJ; Hall RT; Reddy NS; Kurth CG; Merritt TA
    J Pediatr; 1990 Feb; 116(2):295-300. PubMed ID: 2405141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
    Bose C; Corbet A; Bose G; Garcia-Prats J; Lombardy L; Wold D; Donlon D; Long W
    J Pediatr; 1990 Dec; 117(6):947-53. PubMed ID: 2246698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasopharyngeal surfactant administration to prevent neonatal respiratory distress syndrome.
    Fernandes CJ; Horst DA; O'Donovan DJ
    J Perinatol; 2005 May; 25(5):361-2; author reply 363. PubMed ID: 15861205
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind developmental evaluation at 1-year corrected age of 597 premature infants with birth weights from 500 to 1350 grams enrolled in three placebo-controlled trials of prophylactic synthetic surfactant. American Exosurf Neonatal Study Group I.
    Corbet A; Long W; Schumacher R; Gerdes J; Cotton R
    J Pediatr; 1995 May; 126(5 Pt 2):S5-12. PubMed ID: 7745511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory support in preterm infants at birth.
    ;
    Pediatrics; 2014 Jan; 133(1):171-4. PubMed ID: 24379228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovations in cardiopulmonary care of the low-birth-weight infant.
    Cusson RM
    NAACOGS Clin Issu Perinat Womens Health Nurs; 1992; 3(1):62-74. PubMed ID: 1562447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
    Corbet A; Gerdes J; Long W; Avila E; Puri A; Rosenberg A; Edwards K; Cook L
    J Pediatr; 1995 Jun; 126(6):969-78. PubMed ID: 7776110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopmental and respiratory outcome in early childhood after human surfactant treatment.
    Vaucher YE; Merritt TA; Hallman M; Jarvenpaa AL; Telsey AM; Jones BL
    Am J Dis Child; 1988 Sep; 142(9):927-30. PubMed ID: 2458035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
    Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
    J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant.
    Vaucher YE; Harker L; Merritt TA; Hallman M; Gist K; Bejar R; Heldt GP; Edwards D; Pohjavuori M
    J Pediatr; 1993 Jan; 122(1):126-32. PubMed ID: 8419599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analyses of surfactant replacement therapy of infants with birth weights less than 2000 grams.
    Kresch MJ; Clive JM
    J Perinatol; 1998; 18(4):276-83. PubMed ID: 9730197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind evaluation of developmental and health status to age 2 years of infants weighing 700 to 1350 grams treated prophylactically at birth with a single dose of synthetic surfactant or air placebo.
    Kraybill EN; Bose CL; Corbet AJ; Garcia-Prats J; Asbill D; Edwards K; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S33-42. PubMed ID: 7745509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.